Skip to main content
SpringerLink
Log in

Systemic immunoglobulin light-chain amyloidosis presenting hematochezia as the initial symptom

  • Case Report
  • Published:
Clinical Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Immunoglobulin light-chain (AL) amyloidosis is characterized by the deposition of insoluble fibrils composed of immunoglobulin light chains secreted by monoclonal plasma cells. Given the recent advances in the therapy of AL amyloidosis, it is important to diagnose this disease as early as possible. Herein, we describe the case of a 62-year-old man with hepatitis C virus (HCV)-related cirrhosis presenting with hematochezia. Colonoscopy showed multiple submucosal hematomas within the region ranging from the transverse colon to the sigmoid colon. Kappa immunoglobulin light-chain amyloid deposition was also detected. Bone marrow examination revealed a monoclonal abnormal plasma cell population. Thus, the patient was diagnosed with systemic immunoglobulin light-chain amyloidosis. The hematochezia was conservatively managed. However, because of liver failure caused by liver cirrhosis, the patient developed massive pleural effusion and died of respiratory failure. Postmortem examination revealed amyloid deposition in the esophagus, stomach, duodenum, ileum, descending colon, pancreas, heart, and lung. In these organs, amyloid deposition was limited to the vascular wall. We concluded that AL amyloidosis can present hematochezia arising from submucosal hematoma in the large colon before other systemic symptoms appear.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Dispenzieri A, Gertz MA, Buadi F. What do I need to know about immunoglobulin light chain (AL) amyloidosis? Blood Rev. 2012;26:137–54.

    Article  PubMed  Google Scholar 

  2. Rosenzweig M, Landau H. Light chain (AL) amyloidosis: update on diagnosis and management. J Hematol Oncol. 2011;4:47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Cohen AD, Comenzo RL. Systemic light-chain amyloidosis: advances in diagnosis, prognosis, and therapy. Hematol Am Soc Hematol Educ Program. 2010;2010:287–94.

    Google Scholar 

  4. Merlini G, Stone MJ. Dangerous small B-cell clones. Blood. 2006;108:2520–30.

    Article  CAS  PubMed  Google Scholar 

  5. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997;337:898–909.

    Article  CAS  PubMed  Google Scholar 

  6. Matsuda M, Katoh N, Ikeda S. Clinical manifestations at diagnosis in Japanese patients with systemic AL amyloidosis: a retrospective study of 202 cases with a special attention to uncommon symptoms. Intern Med. 2014;53:403–12.

    Article  PubMed  Google Scholar 

  7. Huang X, Wang Q, Jiang S, et al. The clinical features and outcomes of systemic AL amyloidosis: a cohort of 231 Chinese patients. Clin Kidney J. 2015;8:120–6.

    Article  PubMed  Google Scholar 

  8. James DG, Zuckerman GR, Sayuk GS, et al. Clinical recognition of Al type amyloidosis of the luminal gastrointestinal tract. Clin Gastroenterol Hepatol. 2007;5:582–8.

    Article  PubMed  Google Scholar 

  9. Klatt EC. Robbins and cotran atlas of pathology. 2nd ed. United States: Saunders; 2009.

  10. Mumford A, O’Donnell J. Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis. Br J Haematol. 2000;110:454–60.

    Article  CAS  PubMed  Google Scholar 

  11. Thompson CA, Kyle R, Gertz M, et al. Systemic AL amyloidosis with acquired factor X deficiency: a study of perioperative bleeding risk and treatment outcomes in 60 patients. Am J Hematol. 2010;85:171–3.

    PubMed  PubMed Central  Google Scholar 

  12. Choufani EB, Sanchorawala V, Ernst T, et al. Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy. Blood. 2001;97:1885–7.

    Article  CAS  PubMed  Google Scholar 

  13. Spier BJ, Einstein M, Johnson EA, et al. Amyloidosis presenting as lower gastrointestinal hemorrhage. WMJ. 2008;107:40–3.

    PubMed  Google Scholar 

  14. Kim S-Y, Moon S-B, Lee SK, et al. Light-chain amyloidosis presenting with rapidly progressive submucosal hemorrhage of the stomach. Asian J Surg. 2016;39:113–5.

    Article  PubMed  Google Scholar 

  15. Maleszewski JJ. Cardiac amyloidosis: pathology, nomenclature, and typing. Cardiovasc Pathol. 2015;24:343–50.

    Article  CAS  PubMed  Google Scholar 

  16. Yildiz R, Yildirim B, Karincaoglu M, et al. Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients. J Gastroenterol Hepatol. 2005;20:1115–20.

    Article  CAS  PubMed  Google Scholar 

  17. Barbosa M, Guardado J, Marinho C, et al. Cirrhotic cardiomyopathy: isn’t stress evaluation always required for the diagnosis? World J Hepatol. 2016;8:200–6.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We would like to thank Dr. Yuji Kozuka and the staff of the Kuwana West Medical Center clinical laboratory for the pathological studies.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Kuwana West Medical Center, 416-1 Kitabessho, Kuwana, Mie, 511-0819, Japan

    Tetsuo Kon, Naoki Nakagawa, Fumitsugu Yoshikawa, Kazunao Haba, Nagako Kitagawa, Michihiro Izumi, Setsuo Kumazaki, Satoshi Ishida & Ryuichi Aikawa

  2. Department of Internal Medicine, Kuwana South Medical Center, 1 Chome-32-1 Chuocho, Kuwana, Mie, 511-0068, Japan

    Fumitsugu Yoshikawa & Ryuichi Aikawa

Authors
  1. Tetsuo Kon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naoki Nakagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fumitsugu Yoshikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazunao Haba
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nagako Kitagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Michihiro Izumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Setsuo Kumazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Satoshi Ishida
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ryuichi Aikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naoki Nakagawa.

Ethics declarations

Conflict of interest

Tetsuo Kon, Naoki Nakagawa, Fumitsugu Yoshikawa, Kazunao Haba, Nagako Kitagawa, Michihiro Izumi, Setsuo Kumazaki, Satoshi Ishida, and Ryuichi Aikawa declare that they have no conflict of interest.

Human/animal Rights

All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed consent

Informed consent was obtained from all patients for being included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kon, T., Nakagawa, N., Yoshikawa, F. et al. Systemic immunoglobulin light-chain amyloidosis presenting hematochezia as the initial symptom. Clin J Gastroenterol 9, 243–251 (2016). https://doi.org/10.1007/s12328-016-0664-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-016-0664-5

Keywords

Search

Navigation